| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.006 | 1 |